The current landscape for direct-to-consumer genetic testing: Legal, ethical, and policy issues

Annual Review of Genomics and Human Genetics

Volumn 9, Issue , 2008, Pages 161-182

  Hogarth, Stuart ^a   Javitt, Gail ^b   Melzer, David ^c  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

DNA profiling; Government regulation; Personalized genomics

Indexed keywords

ADVERTIZING; CONSUMER; DEVICE; ETHICS; GENE CONTROL; GENETIC ANALYSIS; GENETIC REGULATION; LABORATORY TEST; LAW; LEGAL ASPECT; MEDICAL ETHICS; POLITICS; REVIEW; UNITED STATES;

ADVERTISING AS TOPIC; EUROPE; GENETIC TECHNIQUES; GENETICS, MEDICAL; HUMANS; MARKETING OF HEALTH SERVICES; PUBLIC POLICY; UNITED STATES;

EID: 52949089274     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.9.081307.164319     Document Type: Review

References (90)

1. 23andMe. 2007. http://www.23andme.com
2. Advert. Stand. Auth. (ASA). Codes of Practice. http://www.asa.org.uk/asa/codes/
3. Advis. Comm. Genet. Test. 1999. Third Annual Report and Compendium of Guidance. London: Dep. Health
4. Am. Coll. Med. Genet. 2008. ACMG statement on direct-to-consumer genetic testing. http://www. acmg.net/AM/Template.cfm?Section= Policy_Statements&Template=/CM/ContentDisplay.cfm&ContentID=2975
5. Babygenderinvestigation.com. 2007. Allegations. http://www.babygenderinvestigation.com/ALLEGATIONS.html
6. Baird P. 2002. Identification of genetic susceptibility to common diseases: the case for regulation. Perspect. Biol. Med. 45:516-28
7. Barton D. 2007. EuroGentest workshop on genetic testing and the in vitro diagnostic devices directive. Meet. Rep. http://en.eurogentest.org/ /documents2/1193125494407/Final_Report_EuroGentest_IVDD_Workshop.pdf
8. Cent. Dis. Control Prev. 2004. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing - Atlanta, Denver, Raleigh-Durham, and Seattle. MMWR 53:603-6
9. Clin. Lab. Improv. Amend. (CLIA) 1988. Public Law 100-578, codified at U.S. Code 42, §263a
10. Colliver V. 2007. Home DNA tests create medical, ethical quandaries. San Francisco Chronicle, Aug. 21: C1
11. Counc. Eur. Steer. Comm. Bioeth. 2007. Draft Additional Protocol to the Convention on Human Rights and Biomedicine concerning genetic testing for health purposes and Draft explanatory report to the Additional Protocol to the Convention on Human Rights and Biomedicine concerning genetic testing for health purposes. Strasbourg: Counc. Eur.
12. deCODEme. 2007. http://www.deCodeme.com
13. Dep. Health. 2003. Our Inheritance, Our Future: Realising the Potential of Genetics in the NHS. London: HMSO
14. Dep. Health Hum. Serv. 2007. Personalized Health Care. http://www.dhhs.gov/myhealthcare/
15. DNADirect. 2007. http://www.dnadirect.com
16. EuroGentest. 2007. http://www.eurogentest.org/cocoon/egtorg/web/index. xhtml
17. Eval. Genomic Appl. Pract. Prev. (EGAPP) Work. Group. 2007. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet. Med. 9:819-25
18. Fed. Regist. (May) 2000. 65:25928
19. Fed. Regist. (April) 2006. 71:22595
20. Fed. Trade Comm. 2007. Consumer Alert. http://www.ftc.gov/bcp/ edu/pubs/consumer/health/hea02.shtm
21. Fed. Trade Comm. Act 1914. Codified at United States Code, Title 15, Sections 45 et seq.
22. Food Drug Adm. (FDA). 2007. FDA Draft guidance for industry, clinical laboratories, and FDA staff - In Vitro Diagnostic Multivariate Index Assays http://www.fda.gov/cdrh/oivd/guidance/1610.pdf
23. Food Drug Adm. (FDA). 2007. 510(k) Substantial equivalence determination decision summary for mamma Print (June 4). http://www.fda.gov/cdrh/reviews/K062694.pdf
24. G-Nostics. 2007. NicoTest. http://www.nicotest.com/
25. GeneTests. 2007. http://www.genetests.org
26. GeneTests. 2007. Uses of genetic testing. http://www.genetests. org/servlet/access?id=e888891&key=AceqTkMblNH-3&fcn=y&fw= Sv-&filename=/concepts/primer/primerusesof.html
27. Genet. Health. 2007. http://www.genetic-health.co.uk/
28. Genet. Inf. Nondiscrimination Act of 2007. State. Adm. Policy: H.R. 493
29. Genet. Public Policy Cent. 2007. Survey of direct-to-consumer testing statutes and regulations. http://www.dnapolicy.org/resources/ DTCStateLawChart.pdf
30. Genomics Pers. Med. Act of 2007, S.976, 110th Congr.
31. Genosense. 2007. http://www.genosense.com/EN/Index.html
32. Global Harmonization Task Force. 2007. Study Group 1. Principles of In Vitro Diagnostic (IVD) Medical Devices Classification and Principles of Conformity Assessment for In Vitro Diagnostic (LVD) Medical Devices. http://www.ghtf.org/sg1/sg1-proposed.html
33. Godard B, Kääriäinen H, Kristoffersson U, Tranebjaerg L, Coviello D, Aymé S. 2003. Provision of genetic services in Europe: current practices and issues. Eur. J. Hum. Genet. 11(Suppl. 2):13-48
34. Goddard KA, Moore C, Ottman D, Szegda KL, Bradley L, Khoury MJ. 2007. Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet. Med. 9:510-17
35. Goetz T. 2007. 23andMe will decode your DNA for $1,000: welcome to the age of genomics. Wired Mag. Issue 15(Nov. 17):12
36. Gollust SE, Hull SC, Wilfond BS. 2002. Limitations of direct-to-consumer advertising for clinical genetic testing. JAMA 288:1762
37. Gollust SE, Wilfond BS, Hull SC. 2003. Direct-to-consumer sales of genetic services on the Internet. Genet. Med. 5:332
38. Gutman SI. 2006. Pers. Comms. to Peter Vitulli, President, Sciona, Inc., Howard C. Coleman, Chairman, Genelex Corp., Timothy L. Ramsey, CEO, SureGene, LLC (letters on file with FDA)
39. Haga S, Khoury MJ, Burke W. 2003. Genomic profiling to promote a healthy lifestyle: not ready for prime-time. Nat. Genet. 34:347-50
40. Harris R, Reid M. 1997. 'Medical genetic services in 31 countries: an overview'. Eur. J. Hum. Genet. 5(Suppl. 2):3-21
41. Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern R, Melzer D. 2007. Enhancing the regulation of genetic tests using responsive regulation. Food Drug Law J. 62:831-48
42. Hogarth S, Melzer D. 2007. The IVD Directive and genetic testing: problems and proposals. A briefing presented to the 20th meeting of Competent Authorities. Cambridge, UK: Cambridge Univ.
43. Hogarth S, Melzer D, Zimmern R. 2005. The Regulation of Commercial Genetic testing in the UK, a Briefing for the Human Genetics Commission. Cambridge, UK: Cambridge Univ.
44. Holtzman N, Watson M, eds. 1997. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Baltimore: Johns Hopkins Univ. Press
45. Hudson K, Baruch S, Javitt G. 2005. Genetic testing of human embryos: ethical challenges and policy choices. In Expanding Horizons in Bioethics, ed. AW Galston, CZ Peppard, pp. 103-22. Dordrecht: Springer
46. Hudson K, Javitt G, Burke W, Byers P. 2007. ASHG statement on direct-to-consumer genetic testing in the United States. Am. J. Hum. Genet. 81:635-37
47. Hudson K, Terry S, Lurie P. 2006. Petition for rulemaking. http://www.dnapolicy.org/resources/Petition_For_Rulemaking_September_2006. pdf
48. Hull SC, Prasad K. 2001. Reading between the lines: direct-to-consumer advertising of genetic testing. Hastings Cent. Rep. 31:33-35
49. Hum. Genet. Comm. 2003. Genes direct - Ensuring the effective oversight of genetic tests supplied directly to the public. London: Dep. Health
50. Hum. Genet. Comm. 2007. More genes direct: a report on developments in the availability, marketing and regulation of genetic tests supplied direct to the public. London: Dep. Health
51. Hum. Genet. Comm. 2007. Minutes of the Genes Direct follow-up meeting. http://www.hgc.gov.uk/Client/document.asp?DocId= 125&CAtegoryId=8
52. Ibaretta D, Bock A, Klein C, Rodriguez-Cerezo E. 2003. Towards quality assurance and harmonisation of genetic testing services in the EU. IPTS, Brussels
53. Institute of Medicine. 1994. Assessing Genetic Risks: Implications for Health and Social Policy, ed. LB Andrews, JE Fullarton, NA Holtzman, AG Motulsky. Washington, DC: Natl. Acad. Press
54. Janssens CAJW, Carolina Pardo M, Steyerberg EW, van Duijn CM. 2004. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am. J. Hum. Genet. 74:585-588
55. Javitt G. 2007. In search of a coherent framework: options for FDA oversight of genetic tests. Food Drug Law J. 62:617-52
56. Javitt G. 2006. Pink & Blue? The need for genetic test regulation is black and white. Fertil. Steril. 86:13-15
57. Javitt G, Hudson K. 2006. Public Health at Risk: Failures in Oversight of Genetic Testing Laboratories. Washington, DC: Genet. Public Policy Cent.
58. Javitt G, Hudson K. 2006. Federal neglect: regulation of genetic testing. Issues Sci. Technol. 22:59-66
59. Javitt G, Stanley E, Hudson K. 2004. Direct-to-consumer genetic tests, government oversight, and the first amendment: what the government can (and can't) do to protect the public's health. Okla. Law Rev. 57:251-302
60. Katsanis SH, Javitt G, Hudson K. 2008. A case study of personalized medicine. Science 320:53-54
61. Kenny M. 2007. The ambitious work programme of the European Commission. Regul. Aff. J. Devices 15:73-74
62. Lab. Test Improv. Act of 2007, S.736, 110th Congr.
63. Marcus A. 2003. First ad campaign touts genetic screening for cancer. HealthScout News Sept. 23. http://www.lifeclinic.com/healthnews/ article_view.asp?story=509235
64. Medicare, Medicaid CLIA Programs. 1992. Regulations Implementing the Clinical Laboratoty Improvement Amendments of 1988 (CLIA), 57 Fed. Regist. 7002 (codified in 42 CFR Pt. 405, 410, 416, 417, 418, 440, 482, 483, 484, 485, 488, 491, 493 & 494)
65. MediChecks. 2007. Health Screening Blood Tests. http://www.medichecks.com
66. Medicines (Advert.) Amend. Regul. 2004. (SI 1480)
67. Medicines (Advert.) Regul. 1994. (SI 1932)
68. Medicines Healthcare Products Regulatory Agency. 2003. Advertising Restrictions on Non-Prescription Medicines to be Swept Away. London: MHRA
69. Mouchawar J, Hensley-Alford S, Laurion S, Ellis J, Kulchak-Rahm A, et al. 2005. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet. Med. 7:191-97
70. Myriad Genetics Inc. 2002. Myriad Genetics Launches Direct to Consumer Advertising Campaign for Breast Cancer Test. http://www.corporate-ir. net/ireye/ir_site.zhtml?ticker=mygn&script=413&layou1=9&item_id= 333030
71. Navigenics. 2007. http://www.navigenics.com
72. Nuffield Counc. Bioeth. 1993. Genetic Screening - Ethical Issues. London: Nuffield Trust
73. Offit K. 2008. Genomic profiles for disease risk: predictive or premature? J. Am. Med. Assoc. 299:1353-55
74. Pearson H. 2003. Genetic test adverts under scrutiny. Nature News, 17 Mar. http://www.nature.com/news/2003/030319/full/news030317-3.html
75. Pollack A. 2007. A genetic test that very few need, marketed to the masses. New York Times, Sept. 11
76. Roses AD. 2004. Pharmacogenetics and drug development: the path to safer and more effective drugs. Nat. Rev. Genet. 5:645-56
77. Secretary's Advis. Comm. Genet., Health Soc. (SACGHS) 2008. U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services. Bethesda: Natl. Inst. Health
78. Secretary's Advis. Comm. Genet. Test. 2000. Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT. Bethesda: Natl. Inst. Health
79. Smith DG. 2007. Letter to Kathy Hudson (On file Genet, and Public Policy Cent.) http://www.dnapolicy.org/resources/CMSresponse8.15.07.pdf
80. Suter SM. 2001. The allure and peril of genetics exceptionalism: do we need special genetics legislation? Wash. Univ. Law Q. 79:669-748
81. Scienta Health Center. http://www.scientahealth.com
82. Scott C, Black J. 2000. Cranston's Consumers and the Law. London: Butterworth's
83. Ther. Goods Adm. 2007. The Regulation of Nutrigenetic Tests in Australia: Guidance Document. http://www.tga.gov.au/devices/ivd- nutrigenetic.htm
84. Trade Descr. Act 1968
85. U.S. Congr. 2006. At Home DNA tests: marketing scam or medical breakthrough: hearing before the Special Committee on Aging, 109th Congr., 2n Sess. Senate Hear. 1090-707. Washington, DC
86. U.S. Gov. Account. Off. (GAO) 2006. Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers: GAO-06-977, testimony before the Senate Special Committee on Aging (Statement of Gregory Kutz), pp. 2-27
87. Williams C. 2007. Cancer docs debate gene test ad campaign. ABC News, Sept. 12. http://abcnews.go. com/Health/ CancerPreventionAndTreatrnent/story?id=6588056&page=1
88. Williams S. 2007. Myriad Genetics launches BRCA testing ad campaign in Northeast, GPPC eNews, Sept. 23. http://www.dnapolicy.org/news.enews. article.nocategory.php?action=detail&newsletter_id=26&article_id=111
89. Williams-Jones B. 2003. Where there's a web, there's a way: commercial genetic testing and the internet. Community Genet. 6:46-57
90. Wolfberg AJ. 2006. Genes on the web-direct-to-consumer marketing of genetic testing. N. Engl. J. Med. 355:543-45